Patents by Inventor Andrew HUNTSMAN

Andrew HUNTSMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS
    Publication number: 20220235072
    Abstract: Disclosed herein are compounds, compositions, and methods for inhibiting a histone methyltransferase. The compounds are verticillin derivatives that exhibit anti-proliferative activity against cancer cells. The compounds, compositions, and methods can be used to treat a subject with cancer.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 28, 2022
    Inventors: James Robert FUCHS, Andrew HUNTSMAN, Nicholas Hunter OBERLIES, Chiraz Soumia AMRINE, Huzefa RAJA, Joanna BURDETTE, Cedric PEARCE
  • Antitumor arylnaphthalene ligand glycosides
    Patent number: 10682367
    Abstract: Described are arylnaphthalene lactone derivatives. Also disclosed herein are methods of use of the arylnaphthalene lactone derivatives as anticancer agents.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: June 16, 2020
    Assignee: OHIO STATE INNOVATION FOUNDATION
    Inventors: James Fuchs, Alan Douglas Kinghorn, Andrew Huntsman
  • ANTITUMOR ARYLNAPHTHALENE LIGAND GLYCOSIDES
    Publication number: 20190054105
    Abstract: Described are arylnaphthalene lactone derivatives. Also disclosed herein are methods of use of the arylnaphthalene lactone derivatives as anticancer agents.
    Type: Application
    Filed: April 26, 2017
    Publication date: February 21, 2019
    Inventors: James FUCHS, Alan Douglas KINGHORN, Andrew HUNTSMAN